115 related articles for article (PubMed ID: 22342424)
41. microRNA-99a Restricts Replication of Hepatitis C Virus by Targeting mTOR and de novo Lipogenesis.
Lee EB; Sung PS; Kim JH; Park DJ; Hur W; Yoon SK
Viruses; 2020 Jun; 12(7):. PubMed ID: 32605105
[TBL] [Abstract][Full Text] [Related]
42. HepG2 cells expressing microRNA miR-122 support the entire hepatitis C virus life cycle.
Narbus CM; Israelow B; Sourisseau M; Michta ML; Hopcraft SE; Zeiner GM; Evans MJ
J Virol; 2011 Nov; 85(22):12087-92. PubMed ID: 21917968
[TBL] [Abstract][Full Text] [Related]
43. miR-27b-mediated suppression of aquaporin-11 expression in hepatocytes reduces HCV genomic RNA levels but not viral titers.
Sakurai F; Hashimoto R; Inoue C; Wakabayashi K; Tsukamoto T; Imaizumi T; Andres TGM; Sakai E; Itsuki K; Sakamoto N; Wakita T; Mizuguchi H
Virol J; 2019 May; 16(1):58. PubMed ID: 31046802
[TBL] [Abstract][Full Text] [Related]
44. [Development of an adenovirus vector containing a hepatitis C virus expression cassette and its application].
Yoshida T; Kondoh M; Mizuguchi H; Yagi K
Yakugaku Zasshi; 2013; 133(3):305-11. PubMed ID: 23449406
[TBL] [Abstract][Full Text] [Related]
45. Suppression of leaky expression of adenovirus genes by insertion of microRNA-targeted sequences in the replication-incompetent adenovirus vector genome.
Shimizu K; Sakurai F; Tomita K; Nagamoto Y; Nakamura S; Katayama K; Tachibana M; Kawabata K; Mizuguchi H
Mol Ther Methods Clin Dev; 2014; 1():14035. PubMed ID: 26015975
[TBL] [Abstract][Full Text] [Related]
46. DCAF1 is involved in HCV replication through regulation of miR-122.
Yan Y; Li C; Sun B; Yang R
Arch Virol; 2018 Apr; 163(4):977-985. PubMed ID: 29327233
[TBL] [Abstract][Full Text] [Related]
47. Association between MicroRNA-373 and Long Noncoding RNA NORAD in Hepatitis C Virus-Infected Hepatocytes Impairs Wee1 Expression for Growth Promotion.
Sur S; Sasaki R; Devhare P; Steele R; Ray R; Ray RB
J Virol; 2018 Oct; 92(20):. PubMed ID: 30089699
[TBL] [Abstract][Full Text] [Related]
48. Successful disabling of the 5' UTR of HCV using adeno-associated viral vectors to deliver modular multimeric primary microRNA mimics.
Bourhill T; Arbuthnot P; Ely A
J Virol Methods; 2016 Sep; 235():26-33. PubMed ID: 27181212
[TBL] [Abstract][Full Text] [Related]
49. Preclinical evaluation of an anti-HCV miRNA cluster for treatment of HCV infection.
Yang X; Marcucci K; Anguela X; Couto LB
Mol Ther; 2013 Mar; 21(3):588-601. PubMed ID: 23295950
[TBL] [Abstract][Full Text] [Related]
50. Hepatitis C virus infection modulates expression of interferon stimulatory gene IFITM1 by upregulating miR-130A.
Bhanja Chowdhury J; Shrivastava S; Steele R; Di Bisceglie AM; Ray R; Ray RB
J Virol; 2012 Sep; 86(18):10221-5. PubMed ID: 22787204
[TBL] [Abstract][Full Text] [Related]
51. Improved microRNA suppression by WPRE-linked tough decoy microRNA sponges.
Hollensen AK; Thomsen R; Bak RO; Petersen CC; Ermegaard ER; Aagaard L; Damgaard CK; Mikkelsen JG
RNA; 2017 Aug; 23(8):1247-1258. PubMed ID: 28487381
[TBL] [Abstract][Full Text] [Related]
52. [Development of recombinant adenovirus carrying microRNA-regulated gene expression system].
Sakurai F; Mizuguchi H
Yakugaku Zasshi; 2010 Nov; 130(11):1497-504. PubMed ID: 21048409
[TBL] [Abstract][Full Text] [Related]
53. A PCR-Based Method to Construct Lentiviral Vector Expressing Double Tough Decoy for miRNA Inhibition.
Qiu H; Zhong J; Luo L; Liu N; Kang K; Qu J; Peng W; Gou D
PLoS One; 2015; 10(12):e0143864. PubMed ID: 26624995
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of hepatitis C virus replication using adeno-associated virus vector delivery of an exogenous anti-hepatitis C virus microRNA cluster.
Yang X; Haurigot V; Zhou S; Luo G; Couto LB
Hepatology; 2010 Dec; 52(6):1877-87. PubMed ID: 20931557
[TBL] [Abstract][Full Text] [Related]
55. miR-25 Tough Decoy Enhances Cardiac Function in Heart Failure.
Jeong D; Yoo J; Lee P; Kepreotis SV; Lee A; Wahlquist C; Brown BD; Kho C; Mercola M; Hajjar RJ
Mol Ther; 2018 Mar; 26(3):718-729. PubMed ID: 29273502
[TBL] [Abstract][Full Text] [Related]
56. A potent 2'-O-methylated RNA-based microRNA inhibitor with unique secondary structures.
Haraguchi T; Nakano H; Tagawa T; Ohki T; Ueno Y; Yoshida T; Iba H
Nucleic Acids Res; 2012 Apr; 40(8):e58. PubMed ID: 22259037
[TBL] [Abstract][Full Text] [Related]
57. Adenovirus Vector-Induced IL-6 Promotes Leaky Adenoviral Gene Expression, Leading to Acute Hepatotoxicity.
Shimizu K; Sakurai F; Iizuka S; Ono R; Tsukamoto T; Nishimae F; Nakamura SI; Nishinaka T; Terada T; Fujio Y; Mizuguchi H
J Immunol; 2021 Jan; 206(2):410-421. PubMed ID: 33277385
[TBL] [Abstract][Full Text] [Related]
58. Generation of Efficient miRNA Inhibitors Using Tough Decoy Constructs.
Yoo J; Hajjar RJ; Jeong D
Methods Mol Biol; 2017; 1521():41-53. PubMed ID: 27910040
[TBL] [Abstract][Full Text] [Related]
59. MicroRNA-targeting therapeutics for hepatitis C.
Baek J; Kang S; Min H
Arch Pharm Res; 2014 Mar; 37(3):299-305. PubMed ID: 24385319
[TBL] [Abstract][Full Text] [Related]
60. RNA accessibility impacts potency of Tough Decoy microRNA inhibitors.
Hooykaas MJG; Soppe JA; De Buhr HM; Kruse E; Wiertz EJHJ; Lebbink RJ
RNA Biol; 2018; 15(11):1410-1419. PubMed ID: 30339041
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
